|
Author
|
Stage
|
Type of radiation treatment
|
Total dose
|
Treatment response
|
PFS
|
OS
|
|---|
|
Lindahl et al.[16]
|
T1 5.7%
|
TSEBT
|
High-dose (30 Gy) n = 25
|
High-dose: CR 68%
|
9 months median
|
n. a.
|
| |
T2 40%
| |
Low-dose (4 Gy) n = 10
|
Low-dose:CR 10%
| | |
| |
T3 48.6%
| | | | | |
| |
T4 5.7%
| | | | | |
|
Navi et al.[17]
|
T2 57%
|
TSEBT (+/- HN2)
|
36 Gy (range 30-40 Gy)
|
T2: CCR 75%
|
T2: 8.5 years
|
T2: 10.9 years
|
| |
T3 43%
| | |
T3: CCR 47%
|
T3: 2.9 years
|
T3: 4.7 years
|
|
Kamstrup et al.[16]
|
T2 n = 6
|
TSEBT
|
10 Gy
|
OR 90%
|
median response duration 5.2 months
|
n. a.
|
| |
T3 n = 2
| | |
CR 30%
| | |
| |
T4 n = 2
| | | | | |
|
Chinn et al.[18]
|
T2 n = 55
|
TSEBT (+/- HN2)
|
Mostly 36 Gy
|
T2: CR 76%
|
Freedom from recurrence at 1 year 41%
|
T2: 10.7 years
|
| |
T3 n = 27
| | |
T3: CR 44%
| |
T3: 3.6 years
|
|
This Analysis
|
IIB n = 4
|
TSEBT
|
Median 29 Gy
|
OR 92%
|
5 months
|
10 months
|
| |
III n = 1
| | |
CCR 52%
| | |
| |
IVA n = 10
| | | | | |
| |
IVB n = 7
| | | | | |
- Abbreviations: TSEBT total skin electron beam therapy, CR complete remission, CCR clinical complete remission, OR overall response, PFS progression free survival, OS overall survival.
